Serum levels of sFas and sFasL in subjects with type 2 diabetes — the impact of arterial hypertension
Main Authors: | Stoynev Nikolay, Kalinov Krassimir, Kirilov Georgi, Tankova Tsvetalina |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2014-10-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/med.2014.9.issue-5/s11536-013-0318-7/s11536-013-0318-7.xml?format=INT |
Similar Items
-
Plasma Levels of sFas-sFasL and <i>FASL</i> Gene Expression Are Associated with Tuberculosis
by: Iury de Paula Souza, et al.
Published: (2022-12-01) -
Elevated Concentrations of Soluble Fas and FasL in Multiple Sclerosis Patients with Antinuclear Antibodies
by: Josip Sremec, et al.
Published: (2020-11-01) -
Association of sFas and sFas ligand with progression of type 2 diabetes mellitus in Basrah province
by: Saja Majid Hamid, et al.
Published: (2018-01-01) -
Assiociation between Fas polymorphisms and serum sFas level with rheumatoid arthritis patients in southwest China
by: CHENG Xiao-gang, JIN Hong, CHEN Wei, LUO Dan, SHAN Juan, XU Yan
Published: (2021-11-01) -
High plasma levels of soluble tumor necrosis factor receptor type II (sTNFRII) but low plasma levels of soluble FasL (sFasL) in patients with severe pandemic H1N1 2009 influenza infectio
by: Chintana Phawong, et al.
Published: (2015-05-01)